Wolverine Trading
MGNX icon

Wolverine Trading’s MacroGenics MGNX Stock Holding History

Wolverine Trading’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-44,500
Closed -$142K – 5643
2024
Q3 		$142K Buy
+44,500
New +$173K ﹤0.01% 4242
2021
Q3 		– Sell
-15,500
Closed -$414K – 6677
2021
Q2 		$414K Buy
15,500
+8,800
+131% +$258K ﹤0.01% 3970
2021
Q1 		$208K Buy
+6,700
New +$163K ﹤0.01% 5004
2020
Q4 		– Sell
-9,600
Closed -$242K – 5205
2020
Q3 		$242K Buy
+9,600
New +$262K ﹤0.01% 3648
2019
Q2 		– Sell
-15,400
Closed -$277K – 4853
2019
Q1 		$277K Buy
+15,400
New +$266K ﹤0.01% 3457

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wolverine Trading's MGNX Position: Q2 2021 in Review

Wolverine Trading sold out of MacroGenics (MGNX) in Q2 2021, closing a stake of 7,425 shares — an estimated $217K sold.

Wolverine Trading first reported a position in MGNX in Q1 2019 and held it in 2 quarters. The position peaked at $275K in Q1 2019. 149 funds tracked by Wall St. Rank hold MGNX as of Q2 2021.

  • Wolverine Trading reported no remaining MacroGenics position as of Q2 2021 after selling out during the quarter.
  • Wolverine Trading sold 7,425 MacroGenics shares in Q2 2021, an estimated $217K.
  • Wolverine Trading first reported a position in MacroGenics in Q1 2019 and held it in 2 quarters.
  • Wolverine Trading's MacroGenics position peaked at $275K in Q1 2019.
  • 149 funds tracked by Wall St. Rank held MacroGenics as of Q2 2021.

Based on Wolverine Trading's 13F filing for Q2 2021, filed 6 Aug 2021.